Hu Chen
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- RNA Research and Splicing 14
- RNA modifications and cancer 13
- Ubiquitin and proteasome pathways 10
- Circular RNAs in diseases 9
-
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 17
- Co-authors
- Jinjun Li (4 shared papers)Jianren Gu (4 shared papers)Shengyong Yin (4 shared papers)Haiyang Xie (4 shared papers)Shusen Zheng (4 shared papers)Chao Ge (3 shared papers)Guo‐Ping Jiang (2 shared papers)Ming Yao (2 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (6 papers)Cell Death and Disease (6 papers)PLoS ONE (5 papers)Scientific Reports (4 papers)OncoTargets and Therapy (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Hu Chen
166 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 953
- Oncology 939
- Molecular Biology 2.0k
- Genetics 220
- Hepatology 157
Countries citing papers authored by Hu Chen
This map shows the geographic impact of Hu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Chen more than expected).
Fields of papers citing papers by Hu Chen
This network shows the impact of papers produced by Hu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Chen. The network helps show where Hu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 465 | |
| 2 | 2011 | 150 | |
| 3 | 2008 | 125 | |
| 4 | 2013 | 90 | |
| 5 | 2017 | 84 | |
| 6 | 2014 | 73 | |
| 7 | 2012 | 71 | |
| 8 | 2012 | 67 | |
| 9 | 2015 | 67 | |
| 10 | 2013 | 60 | |
| 11 | 2014 | 57 | |
| 12 | 2016 | 57 | |
| 13 | 2020 | 55 | |
| 14 | 2014 | 54 | |
| 15 | 2017 | 52 | |
| 16 | 2020 | 52 | |
| 17 | Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients. | 2010 | 49 |
| 18 | 2020 | 48 | |
| 19 | 2014 | 47 | |
| 20 | 2016 | 46 |
About Hu Chen
Hu Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Organic Chemistry and Genetics, having authored 176 papers that have together received 3.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (17 papers), RNA Research and Splicing (14 papers), RNA modifications and cancer (13 papers), Mesenchymal stem cell research (13 papers), Ubiquitin and proteasome pathways (10 papers), Circular RNAs in diseases (9 papers) and Autophagy in Disease and Therapy (8 papers). The work is most often cited by research in Cancer Research (953 citations), Oncology (939 citations), Molecular Biology (2.0k citations), Genetics (220 citations) and Hepatology (157 citations). Hu Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jinjun Li, Jianren Gu, Shengyong Yin, Haiyang Xie, Shusen Zheng, Chao Ge, Guo‐Ping Jiang, Ming Yao, Mingxia Yan and Yaosheng Chen. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cell Death and Disease, PLoS ONE, Scientific Reports and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.